Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14218/JCTH.2017.00031 http://scihub22266oqcxt.onion/10.14218/JCTH.2017.00031 C5863001!5863001!29607307     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Transl+Hepatol 2018 ; 6 (1): 69-78 Nephropedia Template TP {{tp|p=29607307|t=2018. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review |pdf=|usr=}}{{29607307}} gab.com Text Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review JO: J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=29607307 #FOAvip Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality. The principal treatment is surgical resection or liver transplantation, depending on whether the patient is a suitable transplant candidate. However, in most patients with HCC the diagnosis is often late, thereby excluding the patients from definitive surgical resection. Medical treatment includes sorafenib, which is the most commonly used systemic therapy; although, it has been shown to only minimally impact patient survival by several months. Chemotherapy and radiotherapy are generally ineffective. Due to the poor prognosis of patients with HCC, newer treatments are needed with several being in development, either in pre-clinical or clinical studies. In this review article, we provide an update on the current and future medical and surgical management of HCC. Twit Text FOAVip Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review ????J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=29607307 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29607307 #FOAvip English Wikipedia <ref>{{Cite pmid|29607307}}</ref> Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review #MMPMID29607307 Daher S; Massarwa M; Benson AA; Khoury T J Clin Transl Hepatol 2018[Mar]; 6 (1): 69-78 PMID29607307show ga Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality. The principal treatment is surgical resection or liver transplantation, depending on whether the patient is a suitable transplant candidate. However, in most patients with HCC the diagnosis is often late, thereby excluding the patients from definitive surgical resection. Medical treatment includes sorafenib, which is the most commonly used systemic therapy; although, it has been shown to only minimally impact patient survival by several months. Chemotherapy and radiotherapy are generally ineffective. Due to the poor prognosis of patients with HCC, newer treatments are needed with several being in development, either in pre-clinical or clinical studies. In this review article, we provide an update on the current and future medical and surgical management of HCC. äCurrent and Future Treatment of Hepatocellular Carcinoma: An Updated C(epmc).pdf DeepDyve Pubget Overpricing